Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 2 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 0 % of short-term debt in 2022; threshold 65 %.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2022
PROMETHERA BIOSCIENCES from Mont-Saint-Guibert, company number BE0809788365, closed financial year 2022 with a result of € -519,541 after tax. For that financial year PROMETHERA BIOSCIENCES recorded a gross margin of € 55,337 and equity of € -1.5 million. Compared with financial year 2021, the result moved from € 16.5 million to € -519,541. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2023.
€ -1.5 million
▼ € 519,542 vs 2021
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -519,541
▼ still € 16.5 million profit in 2021
Profit after tax over the fiscal year.
€ 611
▼ 78% vs 2021
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -63.2 million.
Debts at end 2022
€ 1.6 million
€ 100,000 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.
€ 1.6 million
▼ 6% vs 2021
Supplier invoices still open on the last day of the fiscal year.
€ 150,165
▼ 32% vs 2021
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | Change 2021 → 2022 | |
|---|---|---|---|
| Gross margin | € 18,070,560 | € 55,337 | ▼ € 18 million |
| Profit after taxes | € 16,548,662 | € -519,541 | ▼ € 17.1 million |
| Equity | € -976,490 | € -1,496,032 | ▼ € 519,542 |
| Total debts | € 5,392,609 | € 5,835,526 | ▲ 8% |
| Cash | € 2,833 | € 611 | ▼ 78% |
| Retained profit | € -62,682,207 | € -63,201,749 | ▼ € 519,542 |
| Bank debt | € 1,633,333 | € 1,633,333 | |
| Balance sheet total | € 4,416,119 | € 4,339,494 | ▼ 2% |
| Employees (FTE) | 6.1 | - |
Key figures of PROMETHERA BIOSCIENCES, fiscal years 2021 to 2022, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2023 has not been filed yet; it was expected before 31 July 2024.
What happened to PROMETHERA BIOSCIENCES?
What happened at PROMETHERA BIOSCIENCES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
PROMETHERA BIOSCIENCES is active according to the CBE. Legal situation: Opening faillissement.
- Edward Walter HAACK stepped down as director. NBB
- Bruno DE KEERSMAEKER stepped down as director. NBB
- Hayashi SHINTARO stepped down as director. NBB
- Etienne SOKAL stepped down as director. NBB
- New annual accounts for financial year 2022: loss of € 519,541 (▼ € 17.1 million vs 2021). Source: NBB ↗
- AQ INVEST SPRL stepped down as director. NBB
- Tak fok CHI stepped down as director. NBB
- Bruno DE KEERSMAEKER became a director. NBB
In short
From € 16.5 million profit in 2021 to € 519,541 loss in 2022.
Paid € 4,607 in corporate taxes since 2021.
Best year ever: 2021, with € 16.5 million profit.
On average € 3 million of value added per employee in 2021.
A new publication or filing at PROMETHERA BIOSCIENCES? We notify you, reason included.
Follow PROMETHERA BIOSCIENCESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of SOPARTEC, SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON, INVESTSUD TECH comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PROMETHERA BIOSCIENCESThe shares are held by SOPARTEC (2.6%), SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON (1.3%) and INVESTSUD TECH (1.3%). It owns 20% of Cellaïon SA itself.
Directors
According to the 2022 annual accounts
Edward Walter HAACK
Director
since 2019 · until 2026
Tak fok CHI
Director
since 2020 · until 2022
Bruno DE KEERSMAEKER
Director
since 2022 · until 2026
Managing director · represented by Alain PARTHOENS
Also active at: Ncardia Holding, Newton Biocapital Partners, Newton Biocapital I Investment Pool, DEXOWL, Newton Biocapital II Partners
since 2020 · until 2022
Hayashi SHINTARO
Director
since 2020 · until 2026
Etienne SOKAL
Managing director
since 2019 · until 2026
Reiko NAMIKAWA
Director
since 2019 · until 2022
Shareholders
Participations
20%
Establishments
Establishment units
Physical locations of this company
Rue Granbonpré 11
1435 Mont-Saint-Guibert
Rue Auguste Piccard 37
6041 Charleroi
Active since 1 June 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →DE SMET AGRO
€ 8.7 million revenue · 2025
DE SMET S.A. - ENGINEERS & CONTRACTORS
€ 31.8 million revenue · 2025
CEDRIC CLAERHOUDT
€ 937,969 gross margin · 2024
Tools4Patient
€ -431,027 gross margin · 2025
NOVADIP BIOSCIENCES
€ 1.6 million gross margin · 2025
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0809.788.365
- VAT number
- BE 0809.788.365
- Registered office
- Rue Granbonpré 11, 1435 Mont-Saint-Guibert
- Names & denominations
- PROMETHERA BIOSCIENCES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 12 February 2009
- Peppol
- Not registered
- Activities · NACE
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.